Search Results 921-930 of 14756 for anti-TNF drugs
Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects.
It is also used after an initial treatment plan to treat HER2-positive early breast cancer which has a high risk of occurring again.
... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...
Tapentadol oral solution and tablet are used to treat pain severe enough to require opioid treatment and when other pain medicines did not work well enough or ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alesse; Alesse-28; Altavera; Amethia ...
... anti-PD-1 antibody blockade enhances anti-tumor activity in glioblastoma treatment; Demonstrating that intraperitoneal administration of measles virus-sodium ...
... treatment with adalimumab and/or certolizumab. Must undergo screening for HBV; Baseline CDAI < 200; Has adequate blood and liver test values. Exclusion Criteria.
Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...
Precautions. Drug information provided by: Merative, Micromedex®. If your symptoms do not improve within a few days (or a few weeks or ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Kalexate; Kayexalate; Kionex. Canadian Brand Name.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation can make a difference in the future of healthcare. Give now to support Mayo Clinic's research.